📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. (2019)

First Author: Kounatidou E

Attributed to: MICA: Characterisation of a novel bromodomain inhibitor AZD5153 in castrate resistant prostate cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkz286

PubMed Identifier: 31006810

Publication URI: http://europepmc.org/abstract/MED/31006810

Type: Journal Article/Review

Volume: 47

Parent Publication: Nucleic acids research

Issue: 11

ISSN: 0305-1048